title: Chromotherapy of macular degeneration with transitions lenses and green-yellow medical filters and special programme for psychoorganic disturbances.
abstract: Optical spectrum of the sunlight consists of visible or chromatic spectrum, with the range of wavelengths of electromagnetic vibrations from 7700 to 3900 AU, and the invisible spectrum: infrared and ultraviolet. Chromatic spectrum gives rise to the sensation of colour, capable for simulating specialized retinal photoreceptors and is perceptible as light. This rule of perception of the particular range of the optical spectrum goes mainly for man, while particular deviations, more or less, are applicable to the rest of animal and plant life. The optical part of the spectrum belongs to nonionizing radiation. It created the life on the Earth, maintaining it nowadays and even threatening the human organ of vision, because the retina had not been yet adequately accommodated through evolution with its photoreactive metabolism. Human retina is very sensitive about possible harmful influence of ultraviolet and blue light even today in evolution, but also phototoxic on complete strong visible light. In their clinical and experimental work on animals, the authors prove with their own patent (P 20020077A)-Vojniković B&D, and in collaboration with Essilor Optic Austria GmbH, that particular medical filters in the range of green-yellow colour especially (565 to 570 nm), and in combination with "Transitions" successfully threat macular degeneration-AMD, slowing down its progression and having positive psychoorganic effect on the depressive mood of such patients with threatened sight. Full attention has been paid to the design of medical filter, so the periphery of the lens plays a positive role in blood concentration of melatonin, while the central part stimulates the sight and the concentration of serotonine. Thus the physiological balance of melatonin and serotonin and the stability of psychophysical disturbances have been achieved.
authors.affiliation: Daily Eye Clinic Dr. Bozo Vojniković, Rijeka, Croatia. decv@decv.com
authors.forename: Bozo
authors.initials: B
authors.lastname: Vojniković
authors.forename: Davor
authors.initials: D
authors.lastname: Vojniković
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D002648:Child; D003116:Color; D016500:Color Therapy / Q000379:methods*; D005139:Eyeglasses; D006801:Humans; D008268:Macular Degeneration / Q000517:prevention & control* / Q000523:psychology / Q000628:therapy*; D008875:Middle Aged; D017060:Patient Satisfaction; D013472:Sunlight / Q000009:adverse effects*